title: A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
abstract: Rheumatoid arthritis (RA) is a common, chronic disease where health-related quality of life (HRQL) is one of the main goals of therapy. As such, instruments used to measure HRQL in RA must be able to discriminate across RA severity. The two basic categories of instruments used to measure HRQL are generic instruments and disease-specific instruments. Generic instruments can be further subdivided into preference-based measures which yield both single and multi-attribute utility values anchored at zero (death) and 1.00 (perfect health) as a measure of HRQL. The scores from these types of instruments can be integrated into cost-utility analyses as the weightings for quality adjusted life years. We assessed the construct validity of utility scores from four generic preference-based measures (the Health Utilities Index 2 and 3 (HUI2, HUI3), the EuroQol 5D (EQ-5D), and the Short Form 6-D (SF-6D) and disease specific measures (the Rheumatoid Arthritis Quality of Life Questionnaire (RAQoL) and the Health Assessment Questionnaire (HAQ)) in a sample of 313 RA patients in British Columbia, Canada. We also estimated the minimally important differences (MID) for each of the measures. Generally, as anticipated, the disease-specific measures were better able to discriminate across groups with higher RA severity; however, utility scores from each of the scales also appeared to discriminate well across RA severity categories. The MID values agreed with those previously reported in the literature for the HUI2, SF-6D and the HAQ and provided new information for the HUI3, EQ-5D and the RAQoL. We conclude that the all of the preference-based utility measures that were evaluated appear to adequately discriminate across levels of RA severity.
authors.affiliation: Faculty of Pharmaceutical Sciences, University of British Columbia, Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, 717-828 West 10th Ave, Vancouver, BC, Canada V6Z 1Y6. cmarra@interchange.ubc.ca
authors.forename: Carlo A
authors.initials: CA
authors.lastname: Marra
authors.forename: John C
authors.initials: JC
authors.lastname: Woolcott
authors.forename: Jacek A
authors.initials: JA
authors.lastname: Kopec
authors.forename: Kamran
authors.initials: K
authors.lastname: Shojania
authors.forename: Robert
authors.initials: R
authors.lastname: Offer
authors.forename: John E
authors.initials: JE
authors.lastname: Brazier
authors.forename: John M
authors.initials: JM
authors.lastname: Esdaile
authors.forename: Aslam H
authors.initials: AH
authors.lastname: Anis
mesh_terms: D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000503:physiopathology / Q000523:psychology*; D001955:British Columbia; D002908:Chronic Disease; D003362:Cost-Benefit Analysis; D006801:Humans; D016014:Linear Models; D008875:Middle Aged; D010147:Pain Measurement; D011594:Psychometrics / Q000295:instrumentation*; D011788:Quality of Life; D019057:Quality-Adjusted Life Years; D018434:Sickness Impact Profile; D011795:Surveys and Questionnaires / Q000592:standards*